CN Patent

CN120936346A — 用于改善口服生物利用度的药物组合物

Assigned to Bristol Myers Squibb Co · Expires 2025-11-11 · 1y expired

What this patent protects

根据本披露，已经发现了改善环肽的口服生物利用度的药物配制品。

USPTO Abstract

根据本披露，已经发现了改善环肽的口服生物利用度的药物配制品。

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: CN120936346A
Jurisdiction: CN
Classification: —
Expires: 2025-11-11
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.